Viewing Study NCT02757768

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 5:36 PM
Ignite Modification Date: 2026-02-20 @ 4:49 PM
Study NCT ID: NCT02757768
Status: COMPLETED
Last Update Posted: 2024-11-12
First Post: 2016-04-15
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: A Study to Evaluate the Efficacy, Safety, and Tolerability of Mirabegron in Men With OAB Symptoms While Taking Tamsulosin Hydrochloride for Lower Urinary Tract Symptoms (LUTS) Due to Benign Prostatic Hyperplasia (BPH)
Sponsor: Astellas Pharma Global Development, Inc.
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Benign Prostatic Hyperplasia View
None Overactive Bladder View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Myrbetriq View
None Lower Urinary Tract Symptoms View
None Benign Prostatic Hyperplasia View
None Overactive Bladder View
None Betmiga View
None Mirabegron View
None Tamsulosin Hydrochloride View